Craft

Lantheus Medical Imaging

Stock Price

$110.1

2024-10-29

Market Capitalization

$7.6 B

2024-10-29

Revenue

$1.5 B

FY, 2024

Lantheus Medical Imaging Summary

Company Summary

Overview
Lantheus is a company that develops, manufactures, and commercializes diagnostic imaging agents. It offers radiopharmaceuticals and precision diagnostic products. The company’s products are used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular disease (PVD), and other conditions.
Type
Public
Status
Active
Founded
1956
HQ
Bedford, MA, US | view all locations
Website
https://www.lantheus.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Mary Anne Heino

    Mary Anne Heino, Chief Executive Officer, Director

  • Minnie Baylor-Henry

    Minnie Baylor-Henry, Director

    • Daniel Niedzwiecki

      Daniel Niedzwiecki, Chief Administrative Officer, General Counsel & Corporate Secretary

    • Dorothy Barr

      Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations

      LocationsView all

      4 locations detected

      • Bedford, MA HQ

        United States

        201 Burlington Road, South Building

      • Billerica, MA

        United States

        331 Treble Cove Road

      • Montreal, QC

        Canada

        1111 Boulevard Dr.-Frederik-Philips, Suite 600

      • Lund, Skåne län

        Sweden

        Ideon Science Park, Scheelevägen 27

      Lantheus Medical Imaging Financials

      Summary Financials

      Revenue (Q1, 2025)
      $372.8M
      Gross profit (Q1, 2025)
      $237.7M
      Net income (Q1, 2025)
      $72.9M
      Cash (Q1, 2025)
      $938.5M
      EBIT (Q1, 2025)
      $102.1M
      Enterprise value
      $7.3B

      Footer menu